BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30056149)

  • 1. Selecting the right biologic for your patients with severe asthma.
    Manka LA; Wechsler ME
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):406-413. PubMed ID: 30056149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on biologic-based therapy in asthma.
    Walsh GM
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological treatments for severe asthma: A major advance in asthma care.
    Busse WW
    Allergol Int; 2019 Apr; 68(2):158-166. PubMed ID: 30792118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of biologic therapies for the management of pediatric asthma.
    Lovinsky-Desir S
    Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma.
    Walsh GM
    Expert Rev Respir Med; 2018 Nov; 12(11):957-963. PubMed ID: 30193532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe asthma: When to resort to biological agents.
    Tenero L; Rossignoli S; Piacentini G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():37-39. PubMed ID: 32017206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
    Walsh GM
    Expert Rev Clin Immunol; 2017 Feb; 13(2):143-149. PubMed ID: 27459348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes.
    Kau AL; Korenblat PE
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):570-5. PubMed ID: 25159182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent.
    Krings JG; McGregor MC; Bacharier LB; Castro M
    J Allergy Clin Immunol Pract; 2019; 7(5):1379-1392. PubMed ID: 31076056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging interleukin receptor antagonists for the treatment of asthma.
    Al Efraij K; FitzGerald JM
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):275-283. PubMed ID: 28832218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma.
    Wu AY; Sur S; Grant JA; Tripple JW
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):30-37. PubMed ID: 30407206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
    Peters MC; Wenzel SE
    Lancet; 2020 Feb; 395(10221):371-383. PubMed ID: 32007172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of asthma endotypes: implications for therapy.
    Stokes JR; Casale TB
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic targeted therapy in allergic asthma.
    Bice JB; Leechawengwongs E; Montanaro A
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics for asthma and allergy.
    Walsh GM
    Curr Opin Otolaryngol Head Neck Surg; 2017 Jun; 25(3):231-234. PubMed ID: 28234780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
    Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.